SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

10 Jan 2019 07:00

RNS Number : 6695M
McBride PLC
10 January 2019
 

10 January 2019

 

McBride plc

 

Trading Update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, today provides a trading update for the six months ended 31 December 2018.

 

The Group's first half continuing revenues at constant currency were 10.8% higher than the prior year. Excluding the benefit of first quarter revenues from Danlind, continuing underlying revenues were 6.0% higher. Underlying Household division sales were 5.9% higher, primarily as a result of higher sales in the East and UK regions (up 23.4% and 10.5% respectively).

 

As outlined in our recent AGM trading update, the first half year has seen raw material, packaging and logistics costs higher than anticipated, particularly in the second quarter. These have been partly mitigated by improved sales volumes and lower overheads. The pricing outlook for many of our key raw materials has improved recently and in the absence of this reversing significantly, the Board expects full year earnings to be in line with expectations, with full year profit delivery weighted to the second half.

The sale of the European Personal Care Liquids business was successfully completed during the second quarter and we continue to progress plans for the closure of our UK Aerosols factory in the second half year as expected. The integration of Danlind continued with our Danish factories transitioning onto the McBride ERP system in December.

 

The Group will announce its interim results for the six months ended 31 December 2018 on 21 February.

 

Rik De Vos, Chief Executive said;

 

"The Group has made significant strategic progress in the first half of this financial year completing the sale of Personal Care Liquids, integrating Danlind onto the McBride systems and managing our revenue growth. Margins remain our key focus at present and the recent improvement in the pricing outlook for raw materials following almost two years of significant inflation will see some recovery of the cumulative cost impact to the business. I remain confident that the Group continues to be well positioned to exploit the growth and margin opportunities in the remainder of this financial year and beyond."

 

 

For further information please contact:

 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQKLFBKFFLBBV
Date   Source Headline
1st Sep 20208:13 amRNSHolding(s) in Company
19th Aug 20207:00 amRNSHolding(s) in Company
14th Jul 20207:00 amRNSTrading update
26th Jun 20207:00 amRNSRedemption of B Shares
11th Jun 20207:00 amRNSDirectorate Change
19th May 20207:00 amRNSTrading Update
13th May 20204:35 pmRNSHolding(s) in Company
5th May 20205:00 pmRNSRedemption of B Shares
1st May 20207:00 amRNSChange in Remuneration Committee Responsibilities
28th Apr 20205:05 pmRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSCOVID-19 Update
27th Feb 20205:00 pmRNSDirector/PDMR Shareholding
20th Feb 20207:00 amRNSHalf-year Report
16th Jan 20204:39 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSTrading Update
2nd Dec 20193:16 pmRNSIssue of B Shares as Part of the B Share Scheme
14th Nov 20197:00 amRNSDirectorate Change
6th Nov 20199:32 amRNSDirector/PDMR Shareholding
4th Nov 20194:00 pmRNSDirector/PDMR Shareholding
25th Oct 20193:57 pmRNSDirector/PDMR Shareholding
23rd Oct 20194:49 pmRNSResult of AGM
22nd Oct 20197:00 amRNSAGM Trading Update
15th Oct 20195:01 pmRNSTR1 Notification of major share holdings
8th Oct 20195:12 pmRNSDirector/PDMR Shareholding
8th Oct 20194:04 pmRNSDirector/PDMR Shareholding
8th Oct 20192:54 pmRNSDirector/PDMR Shareholding
7th Oct 20197:00 amRNSAppointment of Chairman Elect
4th Oct 20194:30 pmRNSHolding(s) in Company
4th Oct 20194:30 pmRNSDirector/PDMR Shareholding
4th Oct 20192:05 pmRNSAppointment of CEO and Chairman Succession
30th Sep 20194:12 pmRNSHolding(s) in Company
30th Sep 20194:05 pmRNSHolding(s) in Company
20th Sep 20194:00 pmRNSAnnual Report & Accounts & Notice of AGM
20th Sep 20194:00 pmRNSTotal Voting Rights
12th Sep 201911:06 amRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSFinal Results
17th Jul 20193:18 pmRNSHolding(s) in Company
16th Jul 20194:25 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSTrading Update
26th Jun 20197:00 amRNSDirectorate Change
3rd Jun 20194:30 pmRNSIssue of B Shares as Part of the B Share Scheme
3rd Jun 20197:00 amRNSDirectorate Change
2nd May 20197:00 amRNSDirectorate Change and Trading Update
5th Apr 20192:23 pmRNSDirector/PDMR Shareholding
25th Mar 20194:38 pmRNSDirector Declaration
22nd Feb 201910:14 amRNSHolding(s) in Company
21st Feb 20197:00 amRNSHalf-year Report
20th Feb 20197:00 amRNSTrading Update
10th Jan 20197:00 amRNSTrading Update
4th Dec 20183:26 pmRNSIssue of B Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.